RocRock Biotech, a biomedical innovator, originated from Berlin, Germany, and was founded in Shenzhen in May 2021. The company now operates through a global tripartite structure: its headquarters in Shenzhen, a manufacturing base in Suzhou, and an international R&D center in Berlin. Led by Chinese-European scientists and supported by a team of PhDs from top-tier institutions like the Karolinska Institute (Sweden), EMBL, and the Max Delbrück Center (Germany), RocRock Biotech leverages over ten years of cutting-edge interdisciplinary research to establish itself as a strategic leader in the high-tech biomedical sector.
All study-related tests, medications, and treatments will be covered by the program.
Expert Support: Your participation will be closely monitored by experienced specialists from Xuzhou Medical University Hospital.
Your Privacy Matters: Personal data is protected under strict confidentiality and used solely for medical research purposes.
Protocol for generating humanCAR-engineered macrophage...
DNA origami assembled spheroid for evaluating cytotoxicit...
Tumor micro-environment induced TRAlL secretion from en...
Free AI Website Maker